Gene: YIPF5
Official Full Name: Yip1 domain family member 5provided by HGNC
Gene Summary: Involved in insulin processing and regulation of ER to Golgi vesicle-mediated transport. Located in Golgi apparatus; endoplasmic reticulum; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25754 | YIPF5 Knockout cell line (HeLa) | Human | YIPF5 | 1:3~1:6 | Negative | Online Inquiry |
KO25755 | YIPF5 Knockout cell line (HCT 116) | Human | YIPF5 | 1:2~1:4 | Negative | Online Inquiry |
KO25756 | YIPF5 Knockout cell line (HEK293) | Human | YIPF5 | 1:3~1:6 | Negative | Online Inquiry |
KO25757 | YIPF5 Knockout cell line (A549) | Human | YIPF5 | 1:3~1:4 | Negative | Online Inquiry |
YIPF5 Gene Knockout Cell Lines are engineered cellular models specifically designed to investigate the function of the YIPF5 gene, a key player in cellular processes related to endoplasmic reticulum (ER) structure and function. These knockout cell lines are created through advanced CRISPR/Cas9 gene-editing technologies, effectively disabling the YIPF5 gene to elucidate its biological role and pathway interactions. By providing a controlled environment where YIPF5 is absent, researchers can gain insights into the repercussions of its loss on cellular metabolism, stress response, and protein trafficking.
The YIPF5 gene is critically involved in the maintenance of ER integrity, and its knockout allows for the examination of stress responses that lead to cellular dysfunction and diseases, including neurodegenerative disorders and metabolic syndromes. In clinical research, understanding these cellular mechanisms may highlight potential therapeutic targets and contribute to drug development focusing on ER-related pathologies.
One of the significant advantages of our YIPF5 Gene Knockout Cell Lines over traditional models is their specificity and reliability in mimicking physiological conditions. This established system comes with comprehensive validation to confirm that the knockout has resulted in a complete loss of YIPF5 expression, minimizing off-target effects common in other gene-editing techniques. Furthermore, these cell lines offer ease of use for high-throughput screening, making them invaluable tools for researchers conducting large-scale studies.
The availability of YIPF5 Gene Knockout Cell Lines represents a crucial advancement in the study of cellular biology, offering users the tools necessary to explore the complexities of gene function in a meaningful way. Our commitment to cutting-edge research and development ensures that we provide not only high-quality products but also the expertise and support needed for successful experimentation. Partnering with us, researchers can significantly enhance their capacity to contribute to discoveries within the biological sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.